IL90100A - Combination of antagonist to FAP / synergistic antihistamine against allergy - Google Patents

Combination of antagonist to FAP / synergistic antihistamine against allergy

Info

Publication number
IL90100A
IL90100A IL9010089A IL9010089A IL90100A IL 90100 A IL90100 A IL 90100A IL 9010089 A IL9010089 A IL 9010089A IL 9010089 A IL9010089 A IL 9010089A IL 90100 A IL90100 A IL 90100A
Authority
IL
Israel
Prior art keywords
paf
antihistamine
antagonist
triazolo
methyl
Prior art date
Application number
IL9010089A
Other languages
English (en)
Hebrew (he)
Other versions
IL90100A0 (en
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL90100A0 publication Critical patent/IL90100A0/xx
Publication of IL90100A publication Critical patent/IL90100A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL9010089A 1988-04-27 1989-04-27 Combination of antagonist to FAP / synergistic antihistamine against allergy IL90100A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18653588A 1988-04-27 1988-04-27

Publications (2)

Publication Number Publication Date
IL90100A0 IL90100A0 (en) 1989-12-15
IL90100A true IL90100A (en) 1995-01-24

Family

ID=22685331

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9010089A IL90100A (en) 1988-04-27 1989-04-27 Combination of antagonist to FAP / synergistic antihistamine against allergy

Country Status (15)

Country Link
EP (2) EP0402422A1 (es)
JP (1) JPH0655673B2 (es)
KR (1) KR930009786B1 (es)
AT (1) ATE84724T1 (es)
AU (1) AU619555B2 (es)
CA (1) CA1327316C (es)
DE (1) DE68904475T2 (es)
DK (1) DK255190D0 (es)
ES (1) ES2044100T4 (es)
IE (1) IE63697B1 (es)
IL (1) IL90100A (es)
MY (1) MY106956A (es)
NZ (1) NZ228879A (es)
WO (1) WO1989010143A1 (es)
ZA (1) ZA893101B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
US6277846B1 (en) * 1990-05-31 2001-08-21 Allergan Sales, Inc. Use of platelet activating factor antagonists as anti-pruritic agents
ATE128030T1 (de) * 1990-08-02 1995-10-15 Hoffmann La Roche Antiallergische mischung.
US5227378A (en) * 1990-08-02 1993-07-13 Hoffmann-La Roche Inc. Combination of PAF antagonists and LTD4 antagonists for the treatment of allergic reactions
FR2673842B1 (fr) * 1991-03-13 1993-12-24 Rhone Poulenc Rorer Sa Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4.
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP3060287B2 (ja) * 1995-10-09 2000-07-10 参天製薬株式会社 アパファントを主薬とする水性点眼剤
DE10007203A1 (de) * 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US8492376B2 (en) * 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539332A (en) * 1983-11-14 1985-09-03 Merck & Co., Inc. 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
NZ211146A (en) * 1984-02-29 1987-10-30 Merck & Co Inc 2,5-diaryl-tetrahydrothiophene derivatives and pharmaceutical compositions
US4595693A (en) * 1984-06-04 1986-06-17 Merck & Co., Inc. Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
US4910206A (en) * 1986-07-14 1990-03-20 Sandoz Pharmaceuticals Corp. 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists

Also Published As

Publication number Publication date
DK255190A (da) 1990-10-23
EP0345931A1 (en) 1989-12-13
IL90100A0 (en) 1989-12-15
AU3578289A (en) 1989-11-24
ZA893101B (en) 1989-12-27
DE68904475D1 (de) 1993-03-04
KR900700136A (ko) 1990-08-11
ATE84724T1 (de) 1993-02-15
CA1327316C (en) 1994-03-01
AU619555B2 (en) 1992-01-30
MY106956A (en) 1995-08-30
DK255190D0 (da) 1990-10-23
ES2044100T4 (es) 1996-07-16
ES2044100T3 (es) 1994-01-01
JPH03502097A (ja) 1991-05-16
IE63697B1 (en) 1995-05-31
NZ228879A (en) 1992-08-26
DE68904475T2 (de) 1993-05-13
JPH0655673B2 (ja) 1994-07-27
WO1989010143A1 (en) 1989-11-02
EP0402422A1 (en) 1990-12-19
IE891362L (en) 1989-10-27
EP0345931B1 (en) 1993-01-20
KR930009786B1 (ko) 1993-10-11

Similar Documents

Publication Publication Date Title
JP3778923B2 (ja) ベンゾジアゼピンによる治療における改善
Steele et al. Double-Blind Comparison of the Antiemetic Effects of Nabilone and Prochlorperazine on Chemotherapy-Induced Emesis 1, 2, 3
US20210283094A1 (en) Combination therapy using low-dose doxepin for the improvement of sleep
US5760061A (en) Methods of treating menstrual symptoms and compositions therefore
JPH0621070B2 (ja) ジアゼピン含有医薬組成物
US5059600A (en) Treating habit disorders
US4694010A (en) Anticonvulsant compositions and method
AU740875B2 (en) Novel use of compounds for anti-pruritic activity
EP0345931B1 (en) Certain paf antagonist/antihistamine combinations and methods
KR100567154B1 (ko) 트라마돌을 함유하는 약제학적 배합물
BENOWITZ et al. Depression of growth hormone and cortisol response to insulin-induced hypoglycemia after prolonged oral delta-9-tetrahydrocannabinol administration in man
US5334592A (en) Certain PAF antagonist antihistamine combinations and methods
RU2208013C2 (ru) ПРОИЗВОДНЫЕ 8-ЗАМЕЩЕННОГО-9H-1,3-ДИОКСОЛ/4,5-h//2,3/БЕНЗОДИАЗЕПИНА, ЯВЛЯЮЩИЕСЯ ИНГИБИТОРАМИ AMPA/КАИНАТНОГО РЕЦЕПТОРА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ
US5705506A (en) Pharmaceutical compositions of alkylsulphonamides 5HT1 agonists for rectal administration
JP2003522112A5 (es)
KR20010102240A (ko) 니코틴 의존증 치료를 위한 데옥시페가닌을 포함하는 약학조성물
US6455552B1 (en) Combination of a GABAA α5 inverse agonist and a muscarinic agonist
NL8002041A (nl) Werkwijze voor het bereiden van een analgetisch en myotonolytisch geneesmiddel.
ITRM940322A1 (it) "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione ed applicazione".
CA2262267C (en) Anti-migraine pharmaceutical compositions and process of using
IE903237A1 (en) Paf-antagonists
US4801589A (en) Method for suppressing the immune response
US20060079513A1 (en) Methods and compositions including methscopolamine nitrate
KR960005145B1 (ko) 고혈압 및 울혈성 심부전증 치료용 약학적 조성물
IE903278A1 (en) Use of dopamine-autoreceptor agonists in the treatment of¹drug dependency

Legal Events

Date Code Title Description
KB Patent renewed
RH1 Patent not in force